Evidence map›Paper›PMID 34899940›Full record

ReviewJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2021

Diagnostic and prognostic value of Sepsis-Induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy.

Sayyideh Forough Hosseini, Sahar Behnam-Roudsari, Ghazal Alavinia, Anahita Emami, Arash Toghyani, Sanaz Moradi, Mahtab Mojtahed Zadeh, Sana Mohseni, Mohammad Ali Shafiee

Open access · goldAbstract readReview
In one paragraph

Review in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Sayyideh Forough HosseiniDepartment of Medicine, Division of General Internal Medicine, Toronto General Hospital, Toronto, Canada.
Sahar Behnam-RoudsariDepartment of Medicine, Division of General Internal Medicine, Toronto General Hospital, Toronto, Canada.
Ghazal AlaviniaDepartment of Medicine, Division of General Internal Medicine, Toronto General Hospital, Toronto, Canada.
Anahita EmamiDepartment of Medicine, Division of General Internal Medicine, Toronto General Hospital, Toronto, Canada.
Arash ToghyaniDepartment of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Sanaz MoradiDepartment of Medicine, Division of General Internal Medicine, Toronto General Hospital, Toronto, Canada.
Mahtab Mojtahed ZadehDepartment of Medicine, Division of General Internal Medicine, Toronto General Hospital, Toronto, Canada.
Sana MohseniDepartment of Medicine, Division of General Internal Medicine, Toronto General Hospital, Toronto, Canada.
Mohammad Ali ShafieeDepartment of Medicine, Division of General Internal Medicine, Toronto General Hospital, Toronto, Canada.
Toronto General Hospital · CAIsfahan University of Medical Sciences · IRUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) presents various phenotypes from asymptomatic involvement to death. Disseminated intravascular coagulopathy (DIC) is among the poor prognostic complications frequently observed in critical illness. To improve mortality, a timely diagnosis of DIC is essential. The International Society on Thrombosis and Hemostasis (ISTH) introduced a scoring system to detect overt DIC (score ≥5) and another category called sepsis-induced coagulopathy (SIC) to identify the initial stages of DIC (score ≥4). This study aimed to determine whether clinicians used these scoring systems while assessing COVID-19 patients and the role of relevant biomarkers in disease severity and outcome. MATERIALS AND

methodsAn exhaustive search was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses, using Medline, Embase, Cochrane, CINAHL, and PubMed until August 2020. Studies considering disease severity or outcome with at least two relevant biomarkers were included. For all studies, the definite, maximum, and minimum ISTH/SIC scores were calculated.

resultsA total of 37 papers and 12,463 cases were reviewed. Studies considering ISTH/SIC criteria to detect DIC suggested a higher rate of ISTH ≥5 and SIC ≥4 in severe cases and nonsurvivors compared with nonsevere cases and survivors. The calculated ISTH scores were dominantly higher in severe infections and nonsurvivors. Elevated D-dimer was the most consistent abnormality on admission.

conclusionHigher ISTH and SIC scores positively correlate with disease severity and death. In addition, more patients with severe disease and nonsurvivors met the ISTH and SIC scores for DIC. Given the high prevalence of coagulopathy in COVID-19 infection, dynamic monitoring of relevant biomarkers in the form of ISTH and SIC scoring systems is of great importance to timely detect DIC in suspicious patients.

Indexed as

Coagulopathycoronavirus disease 2019disseminated intravascular coagulationInternational Society on Thrombosis and Hemostasissepsis-induced coagulopathy score

Identifiers

PMID34899940
PMCPMC8607173
OpenAlexW3207656226

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.